Located in Kansas City, Missouri, the Sarah Cannon Transplant & Cellular Therapy Program at Research Medical Center is accredited by FACT for adult autologous transplantation. Established in 2019, our program provides patients convenient, community-based access to complex blood cancer care including clinical trials and innovative therapies.
Research Medical Center is a 590-bed hospital known for being one of the region’s leading acute-care hospitals. Research offers tertiary services, including an ACS Verified Level 1 Trauma Center, a certified Comprehensive Stroke Center, Level 1 STEMI program, ECMO program, Transplant Institute for kidney and pancreas diseases, and Blood and Marrow Transplant through the Sarah Cannon Transplant & Cellular Therapy Program.
The Sarah Cannon Transplant & Cellular Therapy Program at Research Medical Center is part of the Sarah Cannon Transplant & Cellular Therapy Network, which brings together physician-led blood cancer programs across the United States and United Kingdom and is one of the largest providers of transplant and cellular therapies in the world. Our transplant and cellular therapy services are provided in dedicated inpatient and outpatient settings, staffed by a highly trained multidisciplinary care team. Transplant services include educational resources, transplant coordination, financial counseling, social work, and patient housing.
Our mission of service is dedicated to the unique needs of our patients and exemplifies high level commitment to service and support. This commitment continues after transplantation with a focus on access to resources, quality of life and a long-term relationship for our patients and their caregivers.
Contact Email: RHMC.SarahCannon.BloodCancerBMT@hcamidwest.com
Contact Phone: 816-276-4981